Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection

ClinicalTrials.gov ID: NCT04978337

Public ClinicalTrials.gov record NCT04978337. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 10:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection Who Are at High Risk for RSV-related Disease Progression

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy of rilematovir compared to placebo with respect to the time to resolution of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) symptoms.

Study identification

NCT ID
NCT04978337
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Enrollment
5 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 16, 2021
Primary completion
Mar 30, 2022
Completion
Mar 30, 2022
Last update posted
Sep 23, 2024

2021 – 2022

United States locations

U.S. sites
35
U.S. states
16
U.S. cities
31
Facility City State ZIP Site status
Central Alabama Research Birmingham Alabama 35209
Fiel Family and Sports Medicine Clinical Research Advantage Tempe Arizona 85283
IMD Clinical Trials Bakersfield California 93309
Hope clinical Research LLC Canoga Park California 91303
Peninsula Research Associates Rolling Hills Estates California 90274
Bensch Clinical Research, LLC Stockton California 95207
New Life Medical Research Center, Inc. Hialeah Florida 33012
Best Quality Research Inc Hialeah Florida 33016
Homestead Associates in Research, Inc Homestead Florida 33032
Care Partners Clinical Research Jacksonville Florida 32277
Research Institute Of South Florida, Inc. Miami Florida 33173
Pines Care Research Center Inc Pembroke Pines Florida 33024
Santos Research Center Tampa Florida 33615
Privia Medical Group, LLC Fayetteville Georgia 30214
Southcoast Health Savannah Georgia 31406
North Georgia Clinical Research Woodstock Georgia 30189
Chesapeake Clinical Research, Inc. White Marsh Maryland 21162
Montana Medical Research Missoula Montana 59808
Excel Clinical Research Las Vegas Nevada 89109
Burke Primary Care Morganton North Carolina 28655
Dayton Clinical Research Dayton Ohio 45409
Pulmonologist, Critical Care, and Sleep Medicine Wyomissing Pennsylvania 19610
Piedmont Clinical Research Fort Mill South Carolina 29707
Texas Health Care, PLLC Fort Worth Texas 76133
Mercury Clinical Research Houston Texas 77027
Next Level Urgent Care Houston Texas 77057
SW Research LLC Houston Texas 77081
SMS Clinical Research LLC Mesquite Texas 75149
Rio Grande Valley Clinical Research Institute Pharr Texas 78577
Javara San Marcos Texas 78666
Renovatio Clinical The Woodlands Texas 77380
Javara The Woodlands Texas 77384
CCT Research at South Ogden Family Medicine South Ogden Utah 84405
Javara Forest Virginia 24551
Frontier Clinical Research Morgantown West Virginia 26505

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04978337, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 23, 2024 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04978337 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →